Worldwide diffusion of FVII Arg304Gln coagulation defect (FVII Padua)

European Journal of Haematology

Volumn 86, Issue 2, 2011, Pages 135-139

  Girolami, Antonio ^a   Berti De Marinis, Giulia ^a   Bonamigo, Emanuela ^a   Allemand, Emanuele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Arg304Gln mutation; Diffusion; FVII Padua

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 7; GLUTAMINE; THROMBOPLASTIN;

ADULT; AFRICAN AMERICAN; AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MALE; MEDITERRANEAN SEA; PRIORITY JOURNAL; UNITED STATES;

ANIMALS; ARGININE; BLOOD COAGULATION DISORDERS; CATTLE; FACTOR VII; FACTOR VII DEFICIENCY; FEMALE; GLUTAMINE; HOMOZYGOTE; HUMANS; MALE; MUTATION; PLACENTA; PREGNANCY; RABBITS; WORLD HEALTH;

EID: 78651424714     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01544.x     Document Type: Article

References (35)

1. Perry D. Factor VII deficiency. Br J Haematol 2002;118:689-700.
2. Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EG. Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997;78:151-60.
3. Millar DS, Kemball-Cook G, McVey JH, et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000;107:327-42.
4. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978;91:387-95.
5. Girolami A, Patrassi G, Cappellato G, Casonato A. Another family with FVII Padua clotting defect. Acta Haematol 1979;62:4-11.
6. James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VII Padua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta 1993;1172:301-5.
7. James HL, Kumar A, Girolami A, Hubbard J, Fair D. Variant coagulation Factor X and VII with point mutations in a highly conserved motif in the substrate binding pocket, comparative molecular modelling. Thromb Haemost, 1991;69(Suppl.):937 (Abstract).
8. O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EG. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991;78:132-40.
9. Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S. Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 1994;86:610-8.
10. Marty S, Barro C, Chatelain B, Fimbel B, Tribout B, Reynaud J, Schved JF, Giansily-Blaizot M. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia 2008;14:564-70.
11. Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ. Molecular characterization and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost 2000;84:250-7.
12. Takamiya O, McVey I, Kemhell-Cook G, Tuddenham EG. Dysfunctional human FVII variants: detection of missense mutations by PCR and single-strand conformational polymorphism (SSCP). Thromb Haemost 1993;69(Suppl.):1291 (Abstract).
13. Shurafa MS, Kumar A, Fair DS, James HL. The molecular defect in factor VII Detroit is due to substitution of Arg (304) by Glu. FASEB J 1993;7:115 (Abstract).
14. Richmond, R304Q Mutant) associated with thrombosis. Circulation 1992;86(Suppl.):679 (Abstract).
15. Tahatahaly A, Ravanbod S, Baghapour M, Enayat M, Ala F, Rastegar-Lari G. Factor VII genotype and clinical profile in 6 Iranian patients with congenital FVII deficiency. J Thromb Haemost 2007;5(Suppl.):1405 (Abstract).
16. Horellou MH, Chalendard J, Juin F, Conard J, Gouault-Heilmann M, Tapon-Bretaudière J. Source of tissue factor leading to discrepant plasma FVII levels in eight FVII-deficient patients of African origin. J Thromb Haemost 2007;5(Suppl. 2):P-M-002.
17. Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved JF. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001;9:105-12.
18. Fromovich-Amit Y, Zivelin A, Rosenberg N, Landau M, Rosa JP, Seligsohn U. Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis 2005;16:369-74.
19. Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U. Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004;2:1774-81.
20. Kirkel D, Lin TW, Fu SW, Dlott JS, Sahud MA, McCaffrey T, Rickles FR. Asymptomatic factor VII deficiency: gene analysis and structure-function relationships. Blood Coagul Fibrinolysis 2010;21:91-4.
21. Strachan T, Read AP. Human Molecular Genetics. Oxford: Bios Scientific Publishers, 1996: 76 pp.
22. Graham JB, Barrow EM, Hougie C. Stuart clotting defect. II. Genetic aspects of a new hemorrhagic state. J Clin Invest 1957;36:497-503.
23. Girolami A, Molaro G, Orari B. L'ereditarietà della coagulopatia emorragica del Fattore X (Fattore X Friuli). Pobil 1970;77:103-16.
24. Girolami A. The hereditary transmission of congenital "true" hypoprothrombinemia. Br J Haematol 1971;21:695-703.
25. Krauss JS, Matthews A, Oliver J, Lightsey A, Jonah MH, Pantazis CG. African-American factor VII-deficient variants in Georgia (FVII variants). Am J Hematol 1994;47:239-24.
26. Triplett DA, Brandt JT, Batard MA, Schaffer Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985;66:1284-7.
27. Girolami A, Bonamigo E, Vettore S. The lack of ties between northeastern Italy and Afro-American suggest a multifounder effect for FVII Padua (Arg304Gln) disorder. Blood Coag Fibrin (in press).
28. Dokekias AE, Bopaka R, Malanda F, Schved JF. Evaluacion des desordres congenitaux de l'hemostase en el Hopital Universitaire de Brazzaville, Congo. Med Trop 2009;69:102-3.
29. Wulff K, Herrmann FH. Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000;15:489-96.
30. Meade TW. Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease. Am J Cardiol 1990;65:7C-11C.
31. Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304 → Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem 1994;269:7355-63.
32. Girolami A, Dal Bo Zanon R, Zanella F, Procidano M, Ruffato G. FVII Padua defect: the heterozygote population. Acta Haematol 1982;68:34-8.
33. Girolami A, Candeo N, Vettore S, Lombardi AM, Girolami B. The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency. J Thromb Thrombolysis 2010;29:299-302.
34. Mariani G, Herrmann FH, Schulman S, et al. Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003;1:2153-8.
35. Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B. Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis 2010;30:172-8.